Camara, Hawa
Nosi, Somu
Munnull, Gloria
Badman, Steven G
Bolgna, John
Kuk, Joseph
Mola, Glen DL
Guy, Rebecca
Vallely, Andrew J.
Kelly-Hanku, Angela
Funding for this research was provided by:
National Institutes of Health
Article History
Received: 19 July 2022
Accepted: 19 July 2023
First Online: 18 August 2023
Declarations
:
: This study was conducted as part of a National Health and Medical Research Council (NHMRC) funded project grant (GNT1104938) ‘Prospective cohort study to evaluate point-of care HPV-DNA testing for the early detection and treatment of cervical precancer in high-burden, low-resource settings.’ This study was approved by the PNG Institute of Medical Research Institutional Review Board (IRB) (No. 1712), the Medical Research Advisory Committee (MRAC) of the PNG National Department of Health (NDoH) (No. 17.36), and the Human Research Ethics Committee at UNSW Sydney (No. HC17631). All participants signed an informed consent before participating in the interviews. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.